| Vol. 15.04 – 31 January, 2023 |
| |
|
|
| Across consensus molecular subtypes (CMSs), integration of Fusobacterium animalis (Fa) presence and tumor expression reveals that Fa has the most significant associations in mesenchymal CMS4 tumors despite a lower prevalence than in immune CMS1. [Cell Reports Medicine] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| Scientists utilized CD4+ T cells from HNT TCR transgenic mice that developed Th1-like responses upon antigenic stimulation in vitro and in vivo. [Stem Cell Research & Therapy] |
|
|
|
| Investigators co-cultured podocytes and human umbilical cord-MSCs derived exosomes (Exo) under high glucose and injected MSCs-Exo into diabetic mice, then detected the NLRP3 inflammasome both in vitro and in vivo. [Stem Cells] |
|
|
|
| Researchers developed a core–shell structured spheroid with adipose-derived stem cells in the core and human dermal fibroblasts in the outer part of the spheroid. The core–shell structure was formed by continuous centrifugation and spheroid incubation. [Tissue Engineering and Regenerative Medicine] |
|
|
|
| Scientists investigated the effect of exracellular vesicles isolated from hypoxia-pretreated adipose-derived stem cells on human dermal microvascular endothelial cells to attenuate ischemia/reperfusion injury of free skin flaps. [Heliyon] |
| |
|
|
| Researchers selected an appropriate cytokine, IL-18, based on the special cytokine expression profile in severe pneumonia of mice induced by H1N1virus to prime human umbilical cord (hUC)-MSCs in vitro and improved the therapeutic effect of hUC-MSCs in vivo. [Cell Death & Disease] |
|
|
|
| The authors investigated anti-fibrotic efficacy of exosomes derived from human adipose MSCs in vitro and in vivo, and identified important metabolic changes and the detailed mechanism through transcriptomic and metabolomic profiling. [Journal Of Nanobiotechnology] |
|
|
|
| The effect of exosomes derived from human amniotic MSCs on diabetic wound healing were tested by measuring wound closure rates and immunohistochemical staining of CD31. [Tissue Engineering And Regenerative Medicine] |
|
|
|
| The authors developed a novel biosynsphere technology to encapsulate stem cells in clinically-ready biomaterials with controlled microsphere size. [Biomedical Materials] |
|
|
|
|
|
| Investigators review novel findings on the emerging role of mesenchymal cells in the process of development and maintenance of a functional intestinal barrier using insights gained from lineage tracing approaches, Cre-based genes deletion and single cells transcriptomics. [Mucosal Immunology] |
|
|
|
|
| Bone Biologics Corporation announced it has engaged Avania as the contract research organization for the company’s pilot clinical trial with NB1. [Bone Biologics Corporation (BusinessWire, Inc.)] |
|
|
|
|
| April 23 – 26, 2023 Paris, France |
|
|
|
|
|
| University of Florida – Gainesville, Florida, United States |
|
|
|
| The Ottawa Hospital – Ottawa, Ontario, Canada |
|
|
|
| Dresden University of Technology – Dresden, Germany |
|
|
|
| City of Hope – Duarte, California, United States |
|
|
|
| UCLA Jules Stein Eye Institute – Los Angeles, California, United States |
|
|
|
|